Bone morphogenetic proteins-2 and-4: Negative growth regulators in adult retinal pigmented epithelium

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 2, 2000, Pages 592-600

  Mathura Jr , Jeevan R ^a   Jafari, Nadereh ^a   Chang, Jinghua T ^a   Hackett, Sean F ^a   Wahlin, Karl J ^a   Della, Neil G ^a,b   Okamoto, Naoyuki ^a   Zack, Donald J ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; RECOMBINANT PROTEIN; THYMIDINE; TRANSFORMING GROWTH FACTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH REGULATION; HUMAN; HUMAN TISSUE; HYPOXIA; IN SITU HYBRIDIZATION; MOUSE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN EXPRESSION; RETINA ISCHEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REPAIR;

ANIMALS; BLOTTING, NORTHERN; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; CATTLE; CELL DIVISION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; INFANT, NEWBORN; MICE; MICE, INBRED C57BL; PIGMENT EPITHELIUM OF EYE; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RETINA; RETINAL DEGENERATION; RETINOPATHY OF PREMATURITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033973199     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Luyten FP, Cunningham NS, Ma S, et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem. 1989;264:13777-13780.
2. Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan DS. Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science. 1996;271:360-362.
3. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994;8:133-146.
4. Fainsod A, Steinbeisser H, De Robertis EM. On the function of BMP-4 in patterning the marginal zone of the Xenopus embryo. EMBO J. 1994;13:5015-5025.
5. Maeno M, Ong RC., Suzuki A, Teno N, Kung H-F. A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm: roles of animal pole tissue in the development of ventral mesoderm. Proc Natl Acad Sci USA. 1994; 91:10260-10264.
6. Winnier G, Blessing M, Labosky PA, Hogan BLM. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995;9:2105-2116.
7. Barlow AJ, Francis-West PH. Ectopic application of recombinant BMP-2 and BMP-4 can change patterning of developing chick facial primordia. Development. 1997;124:391-398.
8. Yokouchi Y, Sakiyama J, Kameda T, et al. BMP-2/-4 mediate programmed cell death in chicken limb buds. Development. 1996; 122:3725-3734.
9. Zou H, Niswander L. Requirement for BMP signaling in interdigital apoptosis. Science. 1996;272:738-741.
10. Schultheiss TM, Burch JBE, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev. 1997;11:451-462.
11. Ebendal T, Bengtsson H, Soderstrom S. Bone morphogenetic proteins and their receptors: potential functions in brain. J Neurosci Res. 1998;51:139-146.
12. Chang JT, Milligan S, Li Y, et al. Mammalian homolog of drosophila retinal degeneration B rescues the mutant fly phenotype. J Neurosci. 1997;17:5881-5890.
13. Chang JT, Esumi N, Moore K, et al. Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium. Hum Mol Genet. 1999;8:575-583.
14. Swanson DA, Chang JT, Campochiaro PA, Zack DJ, Valle D. Mammalian orthologs of C. elegans unc-119 highly expressed in photoreceptors. Invest Ophthalmol Vis Sci. 1998;39:2085-2094.
15. Wagner M, Perry RP. Characterization of the multigene family encoding the mouse S16 ribosomal protein: strategy for distinguishing an expressed gene from its processed pseudogene counterparts by an analysis of total genomic DNA. Mol Cell Biol. 1985;5:3560-3576.
16. Smith LEH, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
17. Della NG, Campochiaro PA, Zack DJ. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1996;37:1921-1924.
18. Campochiaro PA, Jerdan JA, Glaser BM. The extracellular matrix of human retinal pigmented cells in vivo and its synthesis in vivo. Invest Ophthalmol Vis Sci. 1986;27:1615-1621.
19. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
20. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 1990;31:839-846.
21. Freshney RI, Frame MC. Culture of endothelial cells for the study of angiogenesis in vitro. In: Thilo-Körner DGS, Giessen FRG, Freshney RI, eds. The Endothelial Cell: A Pluripotent Control Cell of the Vessel Wall. Basel: Karger, 1982:13-28.
22. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development. 1991;113:867-878.
23. Farber DB. From mice to men: the cyclic GMP phosphodiesterase gene in vision and disease. The Proctor Lecture. Invest Ophthalmol Vis Sci. 1995;36:263-275.
24. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ Res. 1995;77:638-643.
25. Gerber H-P, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem. 1997;272:23659-23667.
26. Maxwell PH, Dachs GU, Gleadle JM, et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA. 1997;94:8104-8109.
27. Ozaki H, Yu A, Della N, et al. Hypoxia inducible factor-1a is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci. 1998;40:182-189.
28. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor-beta is produced by cultures of endothelial cells and pericytes. Proc Natl Acad Sci USA. 1989;86:4544-4548.
29. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by fibroblast growth factor. Nature. 1990;347:83-86.
30. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos G, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA. 1992;89:11249-11253.
31. Wen R, Song Y, Cheng T, et al. Injury-induced upregulation of bFGF and CNTF mRNAs in the rat retina. J Neurosci. 1995;15: 7377-7385.
32. Sasai Y, Lu B, Steinbeisser H, Geissert D, Gont LK, De Robertis EM. Xenopus chordin: a novel dorsalizing factor activated by organier-specific homeobox genes. Cell. 1994;79:779-790.
33. Sasai Y, Lu B, Steinbeisser H, De Robertis EM. Regulation of neural induction by the chd and BMP-4 patterning signals in Xenopus. Nature. 1995;376:333-336.
34. Smith WC, Harland RM. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell. 1992;70:829-840.
35. Campochiaro PA, Hackett SF, Vinores SA. Growth factors in the retina and retinal pigmented epithelium. Prog Retinal Eye Res. 1996;15:547-567.
36. Campochiaro PA, Hackett SF, Conway BP. Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991;32:65-72.
37. Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol. 1997;115:237-241.
38. Klein R, Klein B. Vision disorders in diabetes. In: Group NDD, ed. Diabetes in America. 2 ed. Washington, DC: National Institutes of Health, 1995:294.
39. Adamis AP, Miller JW, Bernal M-T, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
40. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
41. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994;112:1476-1482.
42. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
43. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
44. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
45. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 1995;92:10457-10461.
46. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LES. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA. 1996;93:4851-4856.
47. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization. Arch Ophthalmol. 1996;114:66-71.
48. Okamoto N, Tobe T, Hackett SF, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol. 1997;151:281-291.
49. Lutty GA, McLeod SD, Merges C, Diggs A, Plouet J. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996;114:971-977.
50. Vinores SA, Youssri AI, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol. 1997;12:99-109.
51. Vinores SA, Chan C-C, Vinores MA, et al. Increased vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-beta) in experimental autoimmune uveoretinitis: up-regulation of VEGF without neovascularization. J Neuroimmunol. 1998;89:43-50.